(PharmaNewsWire.Com, November 01, 2017 ) The North America Superdisintegrants Market was worth USD 103 million in 2016 and estimated to be growing at a CAGR of 7.15%, to reach USD 147.47 million by 2021. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.
Excipients are the substance that is fabricated alongside medicating ingredient for the purpose of long term stabilization, bulking up solid contents etc. Superdisintegrants are one of the types of excipients that help in fragmenting and dissolving the tablet when contacted with water. It provides advantages like faster-medicating action increased effectiveness.
Market Conditions: Major driving forces for the growth of market are development of new superdisintegrants in the pharmaceutical industry, growing generic drugs market and growing population of geriatric and pediatric patients. However, the growth of the market is delayed by the declining financial investments for R&D fields. Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.
North America Superdisintegrants Market Segmentation: • By Product Type: Introduction, Natural Superdisintegrants, Synthetic Superdisintegrants (Modified Starch, Crospovidone, Modified Cellulose, Ion Exchange Resins and Calcium Silicates) and Others • By Application: Introduction, Capsules and Tablets • By Therapeutic Area: Introduction, Gastrointestinal diseases, Neurological diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Haematological diseases and Inflammatory Diseases • By Geography: Introduction, United States and Canada
USA is leading the market while Canada is at second place. Increasing financial support for development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of USA. USA is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness. The synthetic superdisintegrant market segment held the largest share of the North America superdisintegrants market. This is mainly accounted to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.
Key Players: Some of the key players dominating this market include: • Ashland • BASF SE • FMC Corporation • JRS Pharma • DFE Pharma • Roquette • The Dow Chemical Company • Asahi Kasei Corporation • Nippon Soda Co. • Huber Corporation
About MarketDataForecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact: Abhishek Shukla International Business Development Manager Market Data Forecast Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
